Global Market Trends & Growth (2024-2033)

Global Intraocular Lens Market Size, Share & Trends Analysis Report by Type (Monogonal IOLs, Premium IOLs, Phakic IOLs, Others), by Material (Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, Polymethylmethacrylate, Silicone IOLs, Others), by Application (Cataract Surgery, Presbyopia, Corneal Disorders, Others), by End User (Hospitals, Ophthalmology Clinics, Eye Research Institutes, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2024-2032.

Global Intraocular Lens Market size was valued at USD 5.24 Billion in 2023 and is poised to grow from USD 5.54 Billion in 2024 to USD 8.70 Billion by 2032, growing at a CAGR of 5.8 % in the forecast period (2024-2032).

The global intraocular lens (IOL) market has increased significantly over the past few years due to increasing prevalence of cataract and other ocular diseases, coupled with the advances in medical technology. Intraocular lenses form the core of cataract surgery, which is a method through which a natural cloudy lens is exchanged for an artificial one to improve eyesight. They are typically made from biocompatible materials such as silicone or acrylic and implanted into the eye so that patients are able to experience better vision using fewer glasses.

The increasing number of geriatric patients across the globe play a very important part in the growth of the market due to age-related cataracts being among the main reasons for blindness, especially among older populations. Due to the increased rate of longevity, cataract surgery and consequently demand for IOLs will also rise. Other than that, newer technologies have developed sophisticated IOLs with enhanced performance composed of multifocal and accommodating lenses to reduce glasses or contact lens use after surgery. The innovations address the unpredictability of patient demand by offering treatments for other conditions of vision loss.

Apart from this, rising cognition and popularity of cataract surgery for the purpose of refractive improvement are fuelling demand for premium IOLs. Premium IOLs such as multifocal, Toric, and accommodative lenses improve the visual result and patient satisfaction, thus fuelling their rising usage in quality-of-life patients. Apart from this, advancements in minimally invasive technology and surgical instruments have improved over-all cataract surgery success rate, thus fuelling demand for IOLs.

Aside from cataract surgery, IOLs are also being used more and more in the treatment of other ocular conditions such as myopia and presbyopia. The continuous innovation in IOLs for correcting gross visual impairments has opened up new ways to grow in the market.

Increasing number of eye care centres and health care facilities undertaking cataract surgeries, increasing healthcare expenditure and better access to advanced medical equipment are also propelling the growth of the market. With an increasing number of new IOLs coming up, the market will be fuelled by ongoing innovation, which will enable patients to gain increasingly more customized and improved vision correction procedures.

Global Intraocular Lens (IOL) Market Leader in 2025

Alcon Inc.

• Headquarters: Geneva, Switzerland
• Founded: 1945
• Employees: ~25,000
• Revenue (2024): $9.4 billion (IOL business accounts for ~32%)
• Highlights: Market leader with flagship AcrySof IQ IOLs. Pioneering trifocal and toric lens technology. Strong presence in North America, Europe, and APAC.

Johnson & Johnson Vision (J&J Vision)

• Headquarters: Jacksonville, Florida, USA
• Founded: 1981 (acquired by J&J in 2017)
• Employees: ~12,000
• Revenue (2024): ~$5.2 billion (Vision segment)
• Highlights: Offers TECNIS Synergy and Eyhance lenses. Focuses on presbyopia correction and extended vision depth. Leader in R&D and global surgical training programs.

Carl Zeiss Meditec AG

• Headquarters: Jena, Germany
• Founded: 2002
• Employees: ~4,000
• Revenue (2024): €2.6 billion
• Highlights: Premium IOLs like AT LISA tri and CT ASPHINA. Strong performance in EU and expanding in Asia. Zeiss provides integrated surgical systems and optics excellence.

HOYA Corporation (Eyecare Division)

• Headquarters: Tokyo, Japan
• Founded: 1941
• Employees: ~34,000
• Revenue (2024): $5.9 billion (Healthcare segment ~30%)
• Highlights: Vivinex and iSert platforms dominate APAC markets. Known for hydrophobic acrylic lenses and innovation in preloaded IOL delivery systems.

Bausch + Lomb

• Headquarters: Bridgewater, New Jersey, USA
• Founded: 1853
• Employees: ~21,000
• Revenue (2024): $4.5 billion
• Highlights: Offers Akreos and enVista IOLs. Major push in developing countries through affordability initiatives. Expected IPO of surgical division in late 2025.

Rayner Surgical Group

• Headquarters: Worthing, United Kingdom
• Founded: 1910
• Employees: ~1,000
• Revenue (2024): $210 million
• Highlights: Manufacturer of RayOne and Sulcoflex lenses. Innovative fully preloaded injector systems. Rising demand in EU and India.

Aurolab (Aravind Eye Care System)

• Headquarters: Madurai, India
• Founded: 1992
• Employees: ~2,500
• Revenue (2024): ~$80 million
• Highlights: Affordable lenses for LMICs. Plays a key role in reducing cataract blindness globally. Exports to over 120 countries.

STAAR Surgical

• Headquarters: Lake Forest, California, USA
• Founded: 1982
• Employees: ~800
• Revenue (2024): $330 million
• Highlights: Known for implantable collamer lenses (ICL) rather than traditional IOLs, yet diversifying into presbyopia and aphakia solutions.

Ophtec BV

• Headquarters: Groningen, Netherlands
• Founded: 1983
• Employees: ~500
• Revenue (2024): ~$65 million
• Highlights: Specialty in iris reconstruction and trauma lenses. Steady expansion in Latin America and Middle East.

Hanita Lenses (A Sunoptic Company)

• Headquarters: Kibbutz Hanita, Israel
• Founded: 1981
• Employees: ~200
• Revenue (2024): ~$50 million
• Highlights: Growing through OEM partnerships. Offers a wide portfolio of aspheric and multifocal lenses. High uptake in Africa and Eastern Europe.

Regional Analysis (2024–2025)

• North America: Dominates due to high surgical volumes and Medicare coverage.

• Europe: Premium IOL adoption is rising due to aging population and elective procedures.

• Asia-Pacific: Fastest growing; led by India, China, and Indonesia with large unmet needs.

• Latin America & MEA: High growth driven by affordability and government vision programs.

Future Trends in IOL Market (2025–2030)

• AI-Assisted Customization: Personalized IOL selection based on biometric and behavioral data.

• Multifocal & EDOF IOLs: Rising demand for spectacle independence post-surgery.

• Preloaded IOLs: Enhancing surgical efficiency and sterility.

• Hybrid Lenses: Combining accommodative and extended focus features.

• Surge in Emerging Markets: Local manufacturing and training initiatives will expand access.

Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE

About US:

IMIR Market Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

Contact Us: IMIR Market Research Pvt. Ltd.

Follow Us: LinkedIn

Email: sales@intellectualmarketinsights.com

Call Us: +1 (814) 487 8486